Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462332
Status:
COMPLETED
Last Update Posted:
2013-09-06
First Post:
2007-04-18
Brief Title:
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization Data
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Class:
OTHER
Study ID:
LLC0405
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None